Related Experiment Video
Updated: May 1, 2026

Reliable Acquisition of Electroencephalography Data during Simultaneous Electroencephalography and Functional MRI
Published on: March 19, 2021
Are multifocal motor neuropathy patients underdiagnosed? An epidemiological survey in Japan
Introduction:
Our objective was to do an epidemiologic survey of patients with multifocal motor neuropathy (MMN) in comparison with those with amyotrophic lateral sclerosis (ALS) in Japan.
Methods:
In this retrospective study, we examined 46 patients with MMN and 1,051 patients with ALS from major neuromuscular centers in Japan from 2005 to 2009. Diagnosis was based on the European Federation of Neurological Societies/Peripheral Nerve Society (EFNS/PNS) and the revised El Escorial criteria. The efficacy of intravenous immunoglobulin (IVIg) was also taken into consideration in the diagnosis of MMN.
Results:
The ratio of MMN to ALS patients (0–0.10) varied among the centers, but mostly converged to 0.05. The prevalence was estimated to be 0.29 MMN patients and 6.63 ALS patients per 100,000 population.
Conclusions:
The frequency of MMN patients was around 1 out of 20 ALS patients, and MMN was possibly underdiagnosed in some centers.
Insights
Multifocal motor neuropathy (MMN) is diagnosed in approximately 1 in 20 amyotrophic lateral sclerosis (ALS) patients in Japan. Some centers may be underdiagnosing MMN, highlighting the need for increased awareness.
Area of Science:
- Neurology
- Epidemiology
Background:
- Epidemiologic survey comparing multifocal motor neuropathy (MMN) and amyotrophic lateral sclerosis (ALS) patients in Japan.
- Focus on the relative prevalence and diagnostic considerations for MMN versus ALS.
Purpose of the Study:
- To conduct an epidemiologic survey comparing MMN and ALS patients in Japan.
- To estimate the prevalence of MMN in relation to ALS.
Main Methods:
- Retrospective study of 46 MMN and 1,051 ALS patients from 2005-2009.
- Diagnosis based on European Federation of Neurological Societies/Peripheral Nerve Society (EFNS/PNS) and revised El Escorial criteria.
- Inclusion of intravenous immunoglobulin (IVIg) efficacy in MMN diagnosis.
Main Results:
- The MMN to ALS patient ratio varied by center, averaging 0.05.
- Estimated prevalence: 0.29 MMN cases and 6.63 ALS cases per 100,000 population.
Conclusions:
- MMN occurs in approximately 5% of ALS cases in Japan.
- Potential underdiagnosis of MMN in certain Japanese medical centers.
Related Concept Videos
Multiple Sclerosis l: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Bias in Epidemiological Studies
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Diabetic Neuropathy

